Science Clips - Communicable Diseases - RSS http://www.cdc.gov Science Clips (c) 2010, www.cdc.gov Is Neisseria gonorrhoeae initiating a future era of untreatable gonorrhea?: detailed characterization of the first strain with high-level resistance to ceftriaxone Mon, 14 May 2012 http://www.ncbi.nlm.nih.gov/pubmed/21576437 Ohnishi M, Golparian D, Shimuta K, Saika T, Hoshina S, Iwasaku K, Nakayama S, et al.<br />Antimicrob Agents Chemother. 2011 Jul;55(7):3538-45. Communicable Diseases - Multidrug Resistant Gonorrhea High-level cefixime- and ceftriaxone-resistant Neisseria gonorrhoeae in France: novel penA mosaic allele in a successful international clone causes treatment failure Mon, 14 May 2012 http://www.ncbi.nlm.nih.gov/pubmed/22155830 Unemo M, Golparian D, Nicholas R, Ohnishi M, Gallay A, Sednaoui P.<br />Antimicrob Agents Chemother. 2012 Mar;56(3):1273-80. Communicable Diseases - Multidrug Resistant Gonorrhea Antimicrobial resistance in sexually transmitted infections in the developed world: implications for rational treatment Mon, 14 May 2012 http://www.ncbi.nlm.nih.gov/pubmed/22143116 Ison CA.<br />Curr Opin Infect Dis. 2012 Feb;25(1):73-8. Communicable Diseases - Multidrug Resistant Gonorrhea Phenotypic and genotypic properties of Neisseria gonorrhoeae isolates in Norway in 2009: antimicrobial resistance warrants an immediate change in national management guidelines Mon, 14 May 2012 http://www.ncbi.nlm.nih.gov/pubmed/21960034 Hjelmevoll SO, Golparian D, Dedi L, Skutlaberg DH, Haarr E, Christensen A, Jorgensen S, et al.<br />Eur J Clin Microbiol Infect Dis. 2011 Sep 30. Communicable Diseases - Multidrug Resistant Gonorrhea First Neisseria gonorrhoeae strain with resistance to cefixime causing gonorrhoea treatment failure in Austria, 2011 Mon, 14 May 2012 http://www.ncbi.nlm.nih.gov/pubmed/22085601 Unemo M, Golparian D, Stary A, Eigentler A.<br />Euro Surveill. 2011 ;16(43). Communicable Diseases - Multidrug Resistant Gonorrhea Antimicrobial resistance in Neisseria gonorrhoeae in the UK: surveillance and management Mon, 14 May 2012 http://www.ncbi.nlm.nih.gov/pubmed/21973299 Ison CA, Alexander S.<br />Expert Rev Anti Infect Ther. 2011 Oct;9(10):867-76. Communicable Diseases - Multidrug Resistant Gonorrhea Emergence of a Neisseria gonorrhoeae clone showing decreased susceptibility to cefixime in England and Wales Mon, 14 May 2012 http://www.ncbi.nlm.nih.gov/pubmed/21846672 Chisholm SA, Alexander S, Desouza-Thomas L, Maclure-Webster E, Anderson J, Nichols T, Lowndes CM, et al.<br />J Antimicrob Chemother. 2011 Nov;66(11):2509-12. Communicable Diseases - Multidrug Resistant Gonorrhea Surveillance of gonococcal antimicrobial susceptibility resulting in early detection of emerging resistance Mon, 14 May 2012 http://www.ncbi.nlm.nih.gov/pubmed/22334602 Lo JY, Ho KM, Lo AC.<br />J Antimicrob Chemother. 2012 Feb 14. Communicable Diseases - Multidrug Resistant Gonorrhea Impact of fluoroquinolone resistance mutations on gonococcal fitness and in vivo selection for compensatory mutations Mon, 14 May 2012 http://www.ncbi.nlm.nih.gov/pubmed/22492860 Kunz AN, Begum AA, Wu H, D'Ambrozio JA, Robinson JM, Shafer WM, Bash MC, et al.<br />J Infect Dis. 2012 May 3. Communicable Diseases - Multidrug Resistant Gonorrhea A novel mechanism of high-level, broad-spectrum antibiotic resistance caused by a single base pair change in Neisseria gonorrhoeae Mon, 14 May 2012 http://www.ncbi.nlm.nih.gov/pubmed/21933917 Ohneck EA, Zalucki YM, Johnson PJ, Dhulipala V, Golparian D, Unemo M, Jerse AE, et al.<br />MBio. 2011 ;2(5). Communicable Diseases - Multidrug Resistant Gonorrhea Emergence and characterization of Neisseria gonorrhoeae isolates with decreased susceptibilities to ceftriaxone and cefixime in Canada: 2001-2010 Mon, 14 May 2012 http://www.ncbi.nlm.nih.gov/pubmed/22421701 Martin I, Sawatzky P, Allen V, Hoang L, Lefebvre B, Mina N, Wong T, et al.<br />Sex Transm Dis. 2012 Apr;39(4):316-23. Communicable Diseases - Multidrug Resistant Gonorrhea Antibiotic-resistant phenotypes and genotypes of Neisseria gonorrhoeae isolates in Japan: identification of strain clusters with multidrug-resistant phenotypes Mon, 14 May 2012 http://www.ncbi.nlm.nih.gov/pubmed/21844744 Tanaka M, Koga Y, Nakayama H, Kanayama A, Kobayashi I, Saika T, Iyoda T.<br />Sex Transm Dis. 2011 Sep;38(9):871-5. Communicable Diseases - Multidrug Resistant Gonorrhea B lymphocyte-derived humoral immune defenses in breast milk transmission of the HIV-1 Mon, 14 May 2012 http://www.ncbi.nlm.nih.gov/pubmed/22454347 Belec L, <strong>Kourtis AP</strong>.<br />Adv Exp Med Biol. 2012 ;743:139-60. Communicable Diseases Breastfeeding and transmission of HIV-1: epidemiology and global magnitude Mon, 14 May 2012 http://www.ncbi.nlm.nih.gov/pubmed/22454338 Fowler MG, <strong>Kourtis AP</strong>, Aizire J, Onyango-Makumbi C, <strong>Bulterys M</strong>.<br />Adv Exp Med Biol. 2012 ;743:3-25. Communicable Diseases HIV-1 and breastfeeding in the United States Mon, 14 May 2012 http://www.ncbi.nlm.nih.gov/pubmed/22454356 <strong>Little KM</strong>, <strong>Hu DJ</strong>, <strong>Dominguez KL</strong>.<br />Adv Exp Med Biol. 2012 ;743:261-70. Communicable Diseases Cellular immunity in breast milk: implications for postnatal transmission of HIV-1 to the infant Mon, 14 May 2012 http://www.ncbi.nlm.nih.gov/pubmed/22454348 Sabbaj S, Ibegbu CC, <strong>Kourtis AP</strong>.<br />Adv Exp Med Biol. 2012 ;743:161-9. Communicable Diseases HIV-1 virological response and prevalence of HIV-1 drug resistance among patients receiving antiretroviral therapy, Shandong, China Mon, 14 May 2012 http://www.ncbi.nlm.nih.gov/pubmed/22563717 <strong>Zhang J</strong>, <strong>Kang D</strong>, <strong>Lin B</strong>, <strong>Sun X</strong>, <strong>Fu J</strong>, <strong>Bi Z</strong>, <strong>Nkengasong JN</strong>, <strong>Yang C</strong>.<br />AIDS Res Hum Retroviruses. 2012 May 8. Communicable Diseases Moving toward TB elimination: implementation of statewide targeted tuberculin testing in Tennessee Mon, 14 May 2012 http://www.ncbi.nlm.nih.gov/pubmed/22561962 <strong>Cain KP</strong>, Garman KN, <strong>Laserson KF</strong>, Ferrousier-Davis OP, <strong>Miranda AG</strong>, <strong>Wells CD</strong>, Haley CA.<br />Am J Respir Crit Care Med. 2012 May 3. Communicable Diseases Supporting the massive scale-up of antiretroviral therapy: the evolution of PEPFAR-supported treatment facilities in South Africa, 2005-2009 Mon, 14 May 2012 http://www.ncbi.nlm.nih.gov/pubmed/22404862 <strong>Larson E</strong>, <strong>O'Bra H</strong>, Brown J, Mbengashe T, <strong>Klausner JD</strong>.<br />BMC Public Health. 2012 ;12:173. Communicable Diseases HIV drug resistance early warning indicators in cohorts of individuals starting antiretroviral therapy between 2004 and 2009: World Health Organization global report from 50 countries Mon, 14 May 2012 http://www.ncbi.nlm.nih.gov/pubmed/22544188 <strong>Bennett DE</strong>, Jordan MR, Bertagnolio S, Hong SY, Ravasi G, McMahon JH, Saadani A, Kelley KF.<br />Clin Infect Dis. 2012 May;54 Suppl 4:S280-9. Communicable Diseases Virological response and HIV drug resistance 12 months after antiretroviral therapy initiation at 2 clinics in Nigeria Mon, 14 May 2012 http://www.ncbi.nlm.nih.gov/pubmed/22544206 <strong>Ugbena R</strong>, <strong>Aberle-Grasse J</strong>, <strong>Diallo K</strong>, <strong>Bassey O</strong>, <strong>Jelpe T</strong>, <strong>Rottinghaus E</strong>, Azeez A, <strong>Akpan R</strong>, <strong>Muhammad M</strong>, <strong>Shanmugam V</strong>, <strong>Singh S</strong>, <strong>Yang C</strong>.<br />Clin Infect Dis. 2012 May;54 Suppl 4:S375-80. Communicable Diseases Distinct clinical and epidemiological features of tuberculosis in New York City caused by the RD(Rio)Mycobacterium tuberculosis sublineage Mon, 14 May 2012 http://www.ncbi.nlm.nih.gov/pubmed/21835266 Weisenberg SA, Gibson AL, Huard RC, Kurepina N, Bang H, Lazzarini LC, Chiu Y, Li J, Ahuja S, <strong>Driscoll J</strong>, Kreiswirth BN, Ho JL.<br />Infect Genet Evol. 2012 Jun;12(4):664-70. Communicable Diseases Socio-demographic differences in opinions about 2009 pandemic influenza A (H1N1) and seasonal influenza vaccination and disease among adults during the 2009-2010 influenza season Mon, 14 May 2012 http://www.ncbi.nlm.nih.gov/pubmed/22568588 <strong>Santibanez TA</strong>, <strong>Singleton JA</strong>, <strong>Santibanez SS</strong>, <strong>Wortley P</strong>, <strong>Bell BP</strong>.<br />Influenza Other Respi Viruses. 2012 May 9. Communicable Diseases Haemophilus haemolyticus causing clinical disease Mon, 14 May 2012 http://www.ncbi.nlm.nih.gov/pubmed/22573587 <strong>Anderson R</strong>, <strong>Wang X</strong>, <strong>Briere EC</strong>, <strong>Katz LS</strong>, <strong>Cohn AC</strong>, <strong>Clark TA</strong>, <strong>Messonnier NE</strong>, <strong>Mayer LW</strong>.<br />J Clin Microbiol. 2012 May 9. Communicable Diseases Understanding influenza virus resistance to antiviral agents; early warning signs for wider community circulation Mon, 14 May 2012 http://www.ncbi.nlm.nih.gov/pubmed/22561368 <strong>Fry AM</strong>, <strong>Gubareva LV</strong>.<br />J Infect Dis. 2012 May 4. Communicable Diseases Noroviruses: the perfect human pathogens? Mon, 14 May 2012 http://www.ncbi.nlm.nih.gov/pubmed/22573872 <strong>Hall AJ</strong>.<br />J Infect Dis. 2012 Jun;205(11):1622-4. Communicable Diseases HIV-HBV coinfection--a global challenge Mon, 14 May 2012 http://www.ncbi.nlm.nih.gov/pubmed/22571198 <strong>Kourtis AP</strong>, <strong>Bulterys M</strong>, <strong>Hu DJ</strong>, <strong>Jamieson DJ</strong>.<br />N Engl J Med. 2012 May 10;366(19):1749-52. Communicable Diseases Update on World Health Organization HIV drug resistance prevention and assessment strategy: 2004-2011 Mon, 21 May 2012 http://www.ncbi.nlm.nih.gov/pubmed/22544182 Jordan MR, <strong>Bennett DE</strong>, Wainberg MA, Havlir D, Hammer S, <strong>Yang C</strong>, Morris L, Peeters M, Wensing AM, Parkin N, Nachega JB, Phillips A, De Luca A, Geng E, Calmy A, <strong>Raizes E</strong>, Sandstrom P, Archibald CP, Perriens J, McClure CM, Hong SY, McMahon JH, Dedes N, Sutherland D, Bertagnolio S.<br />Clin Infect Dis. 2012 May;54 Suppl 4:S245-9. Communicable Diseases Hospitalizations associated with influenza and respiratory syncytial virus in the United States, 1993-2008 Mon, 21 May 2012 http://www.ncbi.nlm.nih.gov/pubmed/22495079 <strong>Zhou H</strong>, <strong>Thompson WW</strong>, Viboud CG, Ringholz CM, <strong>Cheng PY</strong>, Steiner C, <strong>Abedi GR</strong>, <strong>Anderson LJ</strong>, <strong>Brammer L</strong>, <strong>Shay DK</strong>.<br />Clin Infect Dis. 2012 May;54(10):1427-36. Communicable Diseases World Health Organization generic protocol to assess drug-resistant HIV among children <18 months of age and newly diagnosed with HIV in resource-limited countries Mon, 21 May 2012 Bertagnolio S, Penazzato M, Jordan MR, Persaud D, Mofenson LM, <strong>Bennett DE</strong>.<br />Clin Infect Dis. 2012 15 May;54 Suppl 4:S254-S260. Communicable Diseases Transmitted HIV drug resistance among drug-naive subjects recently infected with HIV in Mexico City: a World Health Organization survey to classify resistance and to field test two alternative patient enrollment methods Mon, 21 May 2012 http://www.ncbi.nlm.nih.gov/pubmed/22544198 Bertagnolio S, Rodriguez-Diaz RA, Fuentes-Romero LL, <strong>Bennett DE</strong>, Viveros-Rogel M, Hart S, Pilon R, Sandstrom P, Soto-Ramirez LE.<br />Clin Infect Dis. 2012 May;54 Suppl 4:S328-33. Communicable Diseases Assessment of physician knowledge and practices concerning Shiga toxin-producing Escherichia coli infection and enteric illness, 2009, Foodborne Diseases Active Surveillance Network (FoodNet) Mon, 21 May 2012 http://www.ncbi.nlm.nih.gov/pubmed/22572668 Clogher P, Hurd S, Hoefer D, Hadler JL, Pasutti L, Cosgrove S, Segler S, Tobin-D'Angelo M, Nicholson C, Booth H, Garman K, <strong>Mody RK</strong>, <strong>Gould LH</strong>.<br />Clin Infect Dis. 2012 Jun;54 Suppl 5:S446-52. Communicable Diseases Monitoring of early warning indicators for HIV drug resistance in antiretroviral therapy clinics in Zimbabwe Mon, 21 May 2012 http://www.ncbi.nlm.nih.gov/pubmed/22544194 Dzangare J, <strong>Gonese E</strong>, Mugurungi O, Shamu T, Apollo T, <strong>Bennett DE</strong>, Kelley KF, Jordan MR, Chakanyuka C, Cham F, Banda RM.<br />Clin Infect Dis. 2012 May;54 Suppl 4:S313-6. Communicable Diseases Prevalence of HIV drug resistance before and 1 year after treatment initiation in 4 sites in the Malawi antiretroviral treatment program Mon, 21 May 2012 http://www.ncbi.nlm.nih.gov/pubmed/22544204 Wadonda-Kabondo N, <strong>Bennett D</strong>, van Oosterhout JJ, Moyo K, Hosseinipour M, <strong>Devos J</strong>, <strong>Zhou Z</strong>, <strong>Aberle-Grasse J</strong>, <strong>Warne TR</strong>, Mtika C, Chilima B, Banda R, Pasulani O, Porter C, Phiri S, Jahn A, Kamwendo D, Jordan MR, Kabuluzi S, Chimbwandira F, Kagoli M, Matatiyo B, <strong>Demby A</strong>, <strong>Yang C</strong>.<br />Clin Infect Dis. 2012 May;54 Suppl 4:S362-8. Communicable Diseases A retrospective survey of HIV drug resistance among patients 1 year after initiation of antiretroviral therapy at 4 clinics in Malawi Mon, 21 May 2012 http://www.ncbi.nlm.nih.gov/pubmed/22544203 Wadonda-Kabondo N, Hedt BL, van Oosterhout JJ, Moyo K, Limbambala E, Bello G, Chilima B, Schouten E, Harries A, Massaquoi M, Porter C, Weigel R, Hosseinipour M, <strong>Aberle-Grasse J</strong>, Jordan MR, Kabuluzi S, <strong>Bennett DE</strong>.<br />Clin Infect Dis. 2012 May;54 Suppl 4:S355-61. Communicable Diseases Evaluation of obesity as an independent risk factor for medically attended laboratory-confirmed influenza Mon, 21 May 2012 http://www.ncbi.nlm.nih.gov/pubmed/22583620 Coleman LA, Waring SC, Irving SA, Vandermause M, <strong>Shay DK</strong>, Belongia EA.<br />Influenza Other Respi Viruses. 2012 May 14. Communicable Diseases Clinical research and development of tuberculosis diagnostics: moving from silos to synergy Mon, 21 May 2012 http://www.ncbi.nlm.nih.gov/pubmed/22476718 Nahid P, Kim PS, Evans CA, Alland D, Barer M, Diefenbach J, Ellner J, Hafner R, Hamilton CD, <strong>Iademarco MF</strong>, Ireton G, Kimerling ME, Lienhardt C, <strong>Mackenzie WR</strong>, Murray M, Perkins MD, <strong>Posey JE</strong>, Roberts T, Sizemore C, Stevens WS, Via L, Williams SD, Yew WW, Swindells S.<br />J Infect Dis. 2012 May;205 Suppl 2:S159-68. Communicable Diseases Antiviral treatment for children with influenza: what's the evidence? Mon, 21 May 2012 http://www.ncbi.nlm.nih.gov/pubmed/22592492 <strong>Garg S</strong>, <strong>Finelli L</strong>, <strong>Fry A</strong>.<br />Pediatr Infect Dis J. 2012 Jun;31(6):662. Communicable Diseases H1N1 influenza vaccination during pregnancy and fetal and neonatal outcomes Mon, 21 May 2012 http://www.ncbi.nlm.nih.gov/pubmed/22515877 Fell DB, Sprague AE, Liu N, Yasseen AS, Wen SW, Smith G, Walker MC.<br />Am J Public Health. 2012 Jun;102(6):e33-40. Communicable Diseases - Influenza Impact of antiviral treatment and hospital admission delay on risk of death associated with 2009 A/H1N1 pandemic influenza in Mexico Mon, 21 May 2012 http://www.ncbi.nlm.nih.gov/pubmed/22520743 Chowell G, Viboud C, Simonsen L, Miller MA, Echevarria-Zuno S, Gonzalez-Leon M, Borja Aburto VH.<br />BMC Infect Dis. 2012 Apr 20;12(1):97. Communicable Diseases - Influenza Vaccination against pandemic A/H1N1 2009 influenza in pregnancy and risk of fetal death: cohort study in Denmark Mon, 21 May 2012 http://www.ncbi.nlm.nih.gov/pubmed/22551713 Pasternak B, Svanstrom H, Molgaard-Nielsen D, Krause TG, Emborg HD, Melbye M, Hviid A.<br />BMJ. 2012 ;344:e2794. Communicable Diseases - Influenza A sentinel platform to evaluate influenza vaccine effectiveness and new variant circulation, Canada 2010-11 season Mon, 21 May 2012 http://www.ncbi.nlm.nih.gov/pubmed/22539661 Skowronski DM, Janjua NZ, De Serres G, Winter AL, Dickinson JA, Gardy JL, Gubbay J, et al.<br />Clin Infect Dis. 2012 Apr 26. Communicable Diseases - Influenza Household transmission of 2009 pandemic influenza A(H1N1): a systematic review and meta-analysis Mon, 21 May 2012 http://www.ncbi.nlm.nih.gov/pubmed/22561117 Lau LL, Nishiura H, Kelly H, Ip DK, Leung GM, Cowling BJ.<br />Epidemiology. 2012 May 3. Communicable Diseases - Influenza Effectiveness of 1 dose of 2009 influenza A (H1N1) vaccine at preventing hospitalization with pandemic H1N1 influenza in children aged 7 months-9 years Mon, 21 May 2012 http://www.ncbi.nlm.nih.gov/pubmed/22551808 Hadler JL, Baker TN, Papadouka V, France AM, Zimmerman C, Livingston KA, Zucker JR.<br />J Infect Dis. 2012 May 11. Communicable Diseases - Influenza Phase 2 assessment of the safety and immunogenicity of two inactivated pandemic monovalent H1N1 vaccines in adults as a component of the U.S. pandemic preparedness plan in 2009 Mon, 21 May 2012 http://www.ncbi.nlm.nih.gov/pubmed/22537984 Chen WH, Winokur PL, Edwards KM, Jackson LA, Wald A, Walter EB, Noah DL, et al.<br />Vaccine. 2012 Apr 23. Communicable Diseases - Influenza Improved neutralizing antibody response in the second season after a single dose of pandemic (H1N1) 2009 influenza vaccine in HIV-1-positive adults Mon, 21 May 2012 http://www.ncbi.nlm.nih.gov/pubmed/22504038 Kikuchi T, Iwatsuki-Horimoto K, Adachi E, Koga M, Nakamura H, Hosoya N, Kawana-Tachikawa A, et al.<br />Vaccine. 2012 Apr 10. Communicable Diseases - Influenza Lack of knowledge of HIV status a major barrier to HIV prevention, care and treatment efforts in Kenya: results from a nationally representative study Mon, 28 May 2012 http://www.ncbi.nlm.nih.gov/pubmed/22574226 Cherutich P, <strong>Kaiser R</strong>, <strong>Galbraith J</strong>, <strong>Williamson J</strong>, <strong>Shiraishi RW</strong>, Ngare C, <strong>Mermin J</strong>, <strong>Marum E</strong>, <strong>Bunnell R</strong>.<br />PLoS One. 2012 ;7(5):e36797. Communicable Diseases Trends in decline of antiretroviral resistance among ARV-experienced patients in the HIV Outpatient Study: 1999-2008 Mon, 28 May 2012 http://www.ncbi.nlm.nih.gov/pubmed/22611484 <strong>Buchacz K</strong>, Baker R, Ward DJ, Palella FJ, Chmiel JS, Young B, Yangco BG, Novak RM, <strong>Brooks JT</strong>.<br />AIDS Res Treat. 2012 ;2012:230290. Communicable Diseases Racial residential segregation and rates of gonorrhea in the United States, 2003-2007 Mon, 28 May 2012 http://www.ncbi.nlm.nih.gov/pubmed/22594733 Biello KB, Kershaw T, <strong>Nelson R</strong>, <strong>Hogben M</strong>, Ickovics J, Niccolai L.<br />Am J Public Health. 2012 May 17. Communicable Diseases Comparison of attitudes about polio, polio immunization, and barriers to polio eradication between primary health center physicians and private pediatricians in India Mon, 28 May 2012 http://www.ncbi.nlm.nih.gov/pubmed/22464934 Thacker N, Choudhury P, Gargano LM, Weiss PS, <strong>Pazol K</strong>, Bahl S, Jafari HS, Arora M, Dubey AP, Vashishtha VM, Agarwal R, Kumar A, Orenstein WA, Omer SB, Hughes JM.<br />Int J Infect Dis. 2012 Jun;16(6):e417-23. Communicable Diseases Aging population and future burden of pneumococcal pneumonia in the United States Mon, 28 May 2012 http://www.ncbi.nlm.nih.gov/pubmed/22448012 Wroe PC, Finkelstein JA, Ray GT, Linder JA, Johnson KM, Rifas-Shiman S, <strong>Moore MR</strong>, Huang SS.<br />J Infect Dis. 2012 May;205(10):1589-92. Communicable Diseases Evaluation of obesity as an independent risk factor for medically attended laboratory-confirmed influenza Mon, 28 May 2012 http://www.ncbi.nlm.nih.gov/pubmed/22583620 Coleman LA, Waring SC, Irving SA, Vandermause M, <strong>Shay DK</strong>, Belongia EA.<br />Influenza Other Respi Viruses. 2012 May 14. Communicable Diseases